HealthExperimental pill combination shrinks tumors in pancreatic cancer trialClinical trial results show daraxonrasib paired with chemotherapy brought advanced tumors under control in 90 percent of patients, researchers reported. By USNOW News DeskNov. 20, 2026, 6:43 AM